Coy Stull is a senior attorney in the firm’s Litigation Department and a member of its Intellectual Property Practice. His experience spans all stages of intellectual property litigation, including trial and appeals. Mr. Stull also has experience in preparation of opinions relating to infringement and validity.

Mr. Stull has represented both plaintiffs and defendants in federal courts, including matters before the International Trade Commission. He has litigated cases in a wide variety of technological areas including: industrial processes, nanomaterials, polymers, consumer products, pharmaceutical compositions, methods of drug delivery and treatment, chemical compounds, natural products and medical diagnostic devices. Mr. Stull’s practice includes experience in pharmaceutical litigation related to Abbreviated New Drug Applications (ANDA) created by the Hatch-Waxman Act. Mr. Stull also has experience with trademark and copyright disputes, including opposition and cancellation proceedings before the Trademark Trial and Appeal Board. Mr. Stull is a registered patent attorney and has experience in advising clients regarding IPRs and ex parte reexaminations.

Areas of Practice
Tätigkeitsfelder
业务范围

Experience

Erfahrung

工作经历

Selected representations include:

  • Ceva Santé Animale and Horizon Valley Generics in a contract and Lanham Act litigation involving fipronil/methoprene veterinary products in the Middle District of Georgia.
  • West-Ward Pharmaceutical in Hatch-Waxman patent infringement litigation brought by Spectrum Pharmaceuticals in the District of Nevada involving patents concerning the drug product Fusilev® (levoleucovorin).
  • Teva Pharmaceuticals USA in Hatch-Waxman patent infringement litigation involving patents listed in the Orange Book and processes for SUBOXONE® (buprenorphine/naloxone sublingual film). Reckitt Benckiser et al v. Teva Pharmaceuticals USA.
  • Watson Laboratories and Andrx Labs in Hatch-Waxman patent infringement litigation involving patents listed in the Orange Book for OXYCONTIN® (extended-release oxycodone hydrochloride tablets). Case settled before trial. Purdue Pharma et al. v. Watson Laboratories et al. (S.D.N.Y.).
Professional Experience

Mr. Stull is a member of the American Intellectual Property Law Association (AIPLA) and the Federal Circuit Bar Association.

Prior to joining Goodwin in 2014, Mr. Stull was an associate in the Washington, D.C. office of Kenyon & Kenyon.

Credentials

Anmeldeinformationen

专业资格

Education

J.D., 2005
University of Miami School of Law

(cum laude)

B.S., Chemical Engineering, 2002
University of Florida
(with honors)

Admissions

Bar

District of Columbia
Florida
U.S. Patent and Trademark Office (USPTO)

Courts

U.S. Supreme Court
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Middle District of Florida
U.S. District Court for the Southern District of Florida
Get In Touch
In Kontakt kommen
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
Suche Andere Rechtsanwälte
搜寻其他律师